This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

PeerVoice Oncology & Haematology Audio

By PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy05/17/2019
    28:35
  2. 2.
    Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions05/03/2019
    25:58
  3. 3.
    Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer04/29/2019
    29:06
  4. 4.
    Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression03/15/2019
    21:05
  5. 5.
    Managing Patients With HER2-Low Breast Cancer02/19/2019
    14:29
  6. 6.
    Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer02/07/2019
    19:41
  7. 7.
    Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy11/26/2018
    1:14:45
  8. 8.
    Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes09/28/2018
    28:08
  1. 9.
    Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma09/20/2018
    19:11
  2. 10.
    Best Practices in Managing CML08/17/2018
    17:59
  3. 11.
    Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer07/04/2018
    19:09
  4. 12.
    Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer06/06/2018
    16:15
  5. 13.
    Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients05/11/2018
    18:38
  6. 14.
    Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco05/09/2018
    8:25
  7. 15.
    The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning05/03/2018
    26:10
  8. 16.
    Emerging Biomarkers in Small-Cell Lung Cancer: A New Era04/30/2018
    16:44
  9. 17.
    Improving Outcomes in Later Lines of Therapy for Metastatic Colorectal Cancer04/11/2018
    18:48
  10. 18.
    New Strategies, New Targets: The Evolving Landscape in Driver-Mutation–Positive Advanced NSCLC04/09/2018
    11:04
  11. 19.
    Improving Outcomes for VTE in Cancer: The Role of Oral Anticoagulants03/19/2018
    20:08
  12. 20.
    Synergistic Approaches in Metastatic Melanoma Treatment: The Rationale for Combination Immunotherapy02/05/2018
    20:50
  13. 21.
    AE Monitoring and Management Strategies for Patients With Metastatic Breast Cancer Receiving Treatment With CDK4/6 Inhibitors01/29/2018
    13:55
  14. 22.
    Journal Club: Review of Recent Data for the Treatment of Stage III, Locally Advanced, Unresectable NSCLC01/22/2018
    13:41
  15. 23.
    Individualizing Care for Optimal Patient Outcomes in Metastatic Melanoma12/22/2017
    9:26
  16. 24.
    Improving QoL in Pre-treated Advanced Breast Cancer: What Are Our Options?12/13/2017
    13:44
  17. 25.
    Back to Basics: What You Need to Know to Identify BCC in Your Patients12/04/2017
    8:14
  18. 26.
    Optimising Outcomes in Advanced Melanoma: The Role of the Pathologist12/01/2017
    16:29
  19. 27.
    Expert Perspectives: Weighing the Evidence for Current and Emerging Therapies in the Management of Advanced Renal Cell Carcinoma10/30/2017
    33:09
  20. 28.
    Multidisciplinary Perspectives on the Future of Pancreatic Cancer Treatment Through the Disease Course: Piecing the Information Together10/18/2017
    1:01:59
  21. 29.
    Optimising Safety of Oral Anticoagulation in Patients With Atrial Fibrillation: How Experts Overcome Clinical Challenges10/04/2017
    16:54
  22. 30.
    Treating Adult ALL in Canada: Expert Guidance on Updated Treatment Protocols09/22/2017
    11:15
  23. 31.
    Current and Emerging Therapies in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck09/18/2017
    15:19
  24. 32.
    An Evolving Era in the Treatment of Recurrent Ovarian Cancer: How Do We Optimise Use of PARP Inhibitors?09/15/2017
    19:16
  25. 33.
    Expert Perspectives on Management of EGFR-Mutated NSCLC: Overcoming Resistance to Ensure Active Lines of Therapy09/13/2017
    24:48
  26. 34.
    The Evolving Landscape for the Treatment of Carcinoid Syndrome09/11/2017
    17:26
  27. 35.
    Using the Data to Optimize Front-Line Immunotherapy in Advanced Melanoma08/30/2017
    18:22
  28. 36.
    Integrating Novel Agents Into Treatment of Relapsed/Refractory Multiple Myeloma: Addressing Current Challenges and Unmet Needs in Brazil08/09/2017
    10:53

Listen to PeerVoice Oncology & Haematology Audio now.

Listen to PeerVoice Oncology & Haematology Audio in full in the Spotify app